US Exempts Select Indian Speciality Drugs From 100% Tariff as Wider Pharma Levy Kicks In
The exemptions cover rare-disease, infertility and gene-therapy drugs as the US implements Trump’s Section 232 pharmaceutical tariff plan.
- The US Commerce Department published a notice in the Federal Register stating that India and 19 other countries are exempt from ad valorem tariffs on specialty drugs and related ingredients.
- President Donald Trump issued a proclamation imposing a 100 per cent tariff on patented pharmaceutical imports under Section 232 of the Trade Expansion Act to encourage domestic production.
- Eligible products for the zero-tariff rate include drugs designated for rare diseases, infertility treatments, gene therapies, and antibody-drug conjugates, or ADCs; components also qualify for exemption.
- While the exemption took effect on July 31 for some companies, it applies to other covered entities starting today, and generic pharmaceutical products remain exempt from Section 232 tariffs.
- Qualifying products from these jurisdictions receive zero per cent tariffs because they maintain a current or forthcoming trade and security framework agreement with the US; "pharmaceutical articles" encompass finished products and key starting materials.
31 Articles
31 Articles
US exempts select Indian speciality drugs from 100% tariff as wider pharma levy kicks in
The US has granted zero-tariff treatment to select speciality medicines from India, including orphan drugs, fertility treatments and cell and gene therapies, as its broader 100% pharmaceutical tariff expands.
U.S. waives tariffs on certain speciality drugs from 20 countries, including India
Eligible products for the zero per cent tariff rate include all drugs designated for rare diseases, infertility treatments, cell therapies, gene therapies, antibody-drug conjugates (ADCs), and animal pharmaceuticals. Components of these drugs are also subject to a zero per cent tariff rate
US Exempts India, 19 Other Nations from 100% Tariff on Speciality Drugs
Get latest articles and stories on Business at LatestLY. The US will exempt speciality medicines for rare conditions from India and 19 other nations from ad valorem tariffs, even as a 100 per cent duty on specified patented pharmaceuticals takes effect on September 29. Generic drugs remain unaffected. Business News | US Exempts India, 19 Other Nations from 100% Tariff on Speciality Drugs.
Coverage Details
Bias Distribution
- 55% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium




















